MD3356F1 - Metoda de tratament al chistului hidatic hepatic - Google Patents

Metoda de tratament al chistului hidatic hepatic Download PDF

Info

Publication number
MD3356F1
MD3356F1 MDA20060275A MD20060275A MD3356F1 MD 3356 F1 MD3356 F1 MD 3356F1 MD A20060275 A MDA20060275 A MD A20060275A MD 20060275 A MD20060275 A MD 20060275A MD 3356 F1 MD3356 F1 MD 3356F1
Authority
MD
Moldova
Prior art keywords
cyst
hydatid
surgery
treatment
invention consists
Prior art date
Application number
MDA20060275A
Other languages
English (en)
Other versions
MD3356G2 (ro
Inventor
Tudor Ababii
Gheorghe Anghelici
Galina Pavliuc
Original Assignee
Tudor Ababii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tudor Ababii filed Critical Tudor Ababii
Priority to MDA20060275A priority Critical patent/MD3356G2/ro
Publication of MD3356F1 publication Critical patent/MD3356F1/ro
Publication of MD3356G2 publication Critical patent/MD3356G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)

Abstract

Inventia se refera la medicina, in special la chirurgie si poate fi folosita pentru tratamentul chistului hidatic hepatic. Esenta inventiei consta inaceea ca se efectueaza interventia chirurgicala cu inlaturarea continutului chistului hidatic, se prelucreaza cavitatea chistului cu solutii antiseptice, se tamponeaza canalele biliare care comunica cu cavitatea chistului, apoi se injecteaza in peretele chistului 5…10 ml de suspensie de celule mononucleare preparata in prealabil din sangele pacientului, care se injecteaza in sah cate 1…2 ml de suspensie la o distanta de 5...6 cm dintre injectari. Rezultatul inventiei consta in reducerea riscului de aparitie a complicatiilor septico-purulente postoperatorii.
MDA20060275A 2006-12-14 2006-12-14 Metodă de tratament al chistului hidatic hepatic MD3356G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060275A MD3356G2 (ro) 2006-12-14 2006-12-14 Metodă de tratament al chistului hidatic hepatic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060275A MD3356G2 (ro) 2006-12-14 2006-12-14 Metodă de tratament al chistului hidatic hepatic

Publications (2)

Publication Number Publication Date
MD3356F1 true MD3356F1 (ro) 2007-07-31
MD3356G2 MD3356G2 (ro) 2008-03-31

Family

ID=38331516

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060275A MD3356G2 (ro) 2006-12-14 2006-12-14 Metodă de tratament al chistului hidatic hepatic

Country Status (1)

Country Link
MD (1) MD3356G2 (ro)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2255G2 (ro) * 2003-01-17 2004-03-31 Георге СТРЭЖЕСКУ Metodă de autodermoplastie a canalelor biliare intrahepatice

Also Published As

Publication number Publication date
MD3356G2 (ro) 2008-03-31

Similar Documents

Publication Publication Date Title
MX2020005345A (es) Un método para inhibir o reducir una infección viral por coronavirus.
Yu et al. Endogenous superoxide dismutase activation by oral administration of riboflavin reduces abdominal aortic aneurysm formation in rats
BR112013005673A2 (pt) uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes
BRPI0414455A (pt) métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins
EA201000897A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
MX2009012197A (es) Metodos para tratamiento de ulceras en la piel.
BR112012027092A2 (pt) métodos e composiões para reduzir ou impedir a calcificação vascular durante a terapia de diálise peritoneal
MX2022006632A (es) Anticuerpos ampliamente neutralizantes contra el vih.
FR2902007B1 (fr) Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s) ainsi que leurs applications notamment therapeutiques
ATE489380T1 (de) Hydratformen von amg706
DE602006017728D1 (de) Krebsbehandlung mittels fts und 2-deoxyglucose
WO2008060535A3 (en) Use of reversine and analogs for treatment of cancer
MD3356F1 (ro) Metoda de tratament al chistului hidatic hepatic
US9687518B2 (en) Medicament for treating muscle and skeletal diseases
RU2012151952A (ru) Способ создания плевродеза
Zeydi et al. Can lidocaine be safely used to reduce pain caused by intramuscular penicillin injections? A short literature review
MD3619G2 (ro) Remediu medicamentos nazal cu acţiune anticongestivă
US20150086529A1 (en) Therapeutic Burn Gel
IS2384B (is) Notkun dókósahexensýru sem virks efnis til að meðhöndla fitukyrking
CL2023003514A1 (es) Composición farmacéutica que comprende ácido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxílico
Reid et al. Hydrogen peroxide–a party trick from the past?
ZA202203668B (en) Methods of treating antipsychotic-induced weight gain with miricorilant
Kvien et al. P306 THE EFFICACY AND SAFETY OF CRX-102-A NOVEL SYNCRETIC DRUG CANDIDATE-IN HAND OSTEOARTHRITIS (HOA): RESULTSFROM A PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL (RCT)
Arora et al. Recent Modification in Vesicular Approaches for Site Specific Delivery of Disease-Modifying Anti-Rheumatic Drugs (Dmrds) and Synovial Replenishers
ATE548038T1 (de) Behandlung von arzneiresistenten tumoren

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees